Evidence map›Paper›PMID 39230651›Full record

Trial reportJournal of racial and ethnic health disparities2025

Racial Differences in Nicotine Reduction: Pooled Results from Two Double-Blind Randomized Controlled Trials.

Wenxue Lin, Nicolle M Krebs, Junjia Zhu, Kimberly Horn, Jonathan Foulds, A Eden Evins, Joshua E Muscat

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of racial and ethnic health disparities, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Wenxue LinDepartment of Epidemiology and Biostatistics, College of Public Health, Temple University, Philadelphia, PA, 19122, USA. wenxuelin90@gmail.com.ORCID 0000-0002-8245-9063
Nicolle M KrebsDepartment of Public Health Sciences, College of Medicine, Pennsylvania State University, Hershey, PA, 17033, USA.
Junjia ZhuDepartment of Public Health Sciences, College of Medicine, Pennsylvania State University, Hershey, PA, 17033, USA.ORCID 0000-0003-1311-3752
Kimberly HornDepartment of Population Health Sciences, Virginia Tech Carilion Research Institute, Roanoke, VA, 24016, USA.
Jonathan FouldsDepartment of Public Health Sciences, College of Medicine, Pennsylvania State University, Hershey, PA, 17033, USA.ORCID 0000-0003-2296-0726
A Eden EvinsCenter for Addiction Medicine, Department of Psychiatry, Massachusetts General Hospital, Boston, MA, 02114, USA.
Joshua E MuscatDepartment of Public Health Sciences, College of Medicine, Pennsylvania State University, Hershey, PA, 17033, USA.

Funding

Project 3: Randomized Placebo-controlled Trial of Nicotine Pouches in SmokersU54DA058271 · NIDA · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI JONATHAN FOULDS, JOSHUA E MUSCAT · 2023 to 2026
$19.7M
Research Training and Educational Component (Component I) p370-385P50DA036107 · NIDA · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI FOULDS, JONATHAN, MUSCAT, JOSHUA E · 2013 to 2018
$19.5M
Center for Tobacco Products P50DA036107-05S1NIDA NIH HHS P50 DA036107NIDA NIH HHS P50DA036107NIDA NIH HHS U54 DA058271
6 · The paper itself

Abstract

introductionTobacco regulatory policies are generally intended to apply to all segments of the population and to be equitable. Results from clinical trials on switching from commercial cigarettes to reduced nicotine cigarettes have included black populations but race-specific findings are not widely reported.

methodsData were pooled from two parallel randomized controlled trials of gradually reduced nicotine in cigarettes from 11.6 mg per cigarette down to 0.2 mg nicotine (very low nicotine content; VLNC) vs. usual nicotine content (UNC) cigarettes (11.6 mg) over an 18-week period in smokers with low socioeconomic status (SES) and mental health conditions, respectively. We used linear regression to determine the potential effects of cigarettes and biomarker reductions (blood cotinine and exhaled carbon monoxide) when using VLNC study cigarettes. An intention-to-treat (ITT) analysis included all randomized participants regardless of adherence to the protocol. A secondary compliance analysis compared control subjects (11.6 mg cigarettes) only to those switched to low nicotine cigarettes who were biochemically determined to be compliant to exclusively using VLNC cigarettes.

resultsBoth Black and White VLNC smokers had significantly lower plasma cotinine and exhaled carbon monoxide compared to those randomized to UNC cigarettes. The treatment × race interaction term was not significant for the outcome measures in both the ITT and secondary compliance analyses, except for cotinine in the ITT analysis (Whites: - 190 ng/mL vs. Blacks: - 118 ng/mL; p = 0.05).

conclusionsA reduced nicotine regulation for cigarettes would result in substantial reduction in exposure to nicotine and toxicants in Black and White smokers.

Indexed as

Black or African AmericanNicotineSmoking CessationTobacco ProductsWhite PeopleAdultCarbon MonoxideCotinineDouble-Blind MethodFemaleHumansMaleMiddle AgedCarbon MonoxideCotinineNicotineRacial differencesRandomized controlled trialReduced nicotine contentUsual nicotine content

Identifiers

PMID39230651
PMCPMC12204058

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.